|
1
|
Zaio R, Carinelli SG, Ellenson LH, Eng C,
Katabuchi H, Konishi I, Lax S, Matias-Guiu X, Mutter GL, Peters WA
III, et al: Epithelial tumours and precursors. In: Kurman RJ
Carcangiu ML Herrington S and Young RH (eds). WHO classification of
tumours of female reproductive organs. 4th edition. Lyon, IARC.
pp125–135. 2014.
|
|
2
|
Pocrnich CE, Ramalingam P, Euscher ED and
Malpica A: Neuroendocrine carcinoma of the endometrium: A
clinicopathologic study of 25 cases. Am J Surg Pathol. 40:577–586.
2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ishida M, Iwamoto N, Nakagawa T, Kaku S,
Iwai M, Kagotani A, Takahashi K, Murakami T and Okabe H: Small cell
carcinoma of the endometrium: A case report with emphasis on the
cytological features. Int J Clin Exp Pathol. 7:3332–3337.
2014.PubMed/NCBI
|
|
4
|
Adachi K, Nikaido I, Ohta H, Ohtsuka S,
Ura H, Kadota M, Wakayama T, Ueda HR and Niwa H: Context-dependent
wiring of Sox2 regulatory networks for self-renewal of embryonic
and trophoblast stem cells. Mol Cell. 52:380–392. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sholl LM, Long KB and Hornick JL: Sox2
expression in pulmonary non-small cell and neuroendocrine
carcinomas. Appl Immunohistochem Mol Morphol. 18:55–61.
2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Shima H, Kutomi G, Satomi F, Maeda H,
Hirohashi Y, Hasegawa T, Mori M, Torigoe T and Takemasa I: SOX2 and
ALDH1 as predictors of operable breast cancer. Anticancer Res.
36:2945–2953. 2016.PubMed/NCBI
|
|
7
|
Basati G, Mohammadpour H and Emami Razavi
A: Association of high expression levels of SOX2, NANOG, and OCT4
in gastric cancer tumor tissues with progression and poor
prognosis. J Gastrointest Cancer. 51:41–47. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Herreros-Villanueva M, Bujanda L,
Billadeau DD and Zhang JS: Embryonic stem cell factors and
pancreatic cancer. World J Gastroenterol. 20:2247–2254.
2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Santini R, Pietrobono S, Pandolfi S,
Montagnani V, D'Amico M, Penachioni JY, Vinci MC, Borgognoni L and
Stecca B: SOX2 regulates self-renewal and tumorigenicity of human
melanoma-initiating cells. Oncogene. 33:4697–4708. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yamawaki K, Ishiguro T, Mori Y, Yoshihara
K, Suda K, Tamura R, Yamaguchi M, Sekine M, Kashima K, Higuchi M,
et al: Sox2-dependent inhibition of p21 is associated with poor
prognosis of endometrial cancer. Cancer Sci. 108:632–640.
2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lee CJ, Sung PL, Kuo MH, Tsai MH, Wang CK,
Pan ST, Chen YJ, Wang PH, Wen KC and Chou YT: Crosstalk between
SOX2 and cytokine signaling in endometrial carcinoma. Sci Rep.
8(17550)2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Pityński K, Banas T, Pietrus M,
Milian-Ciesielska K, Ludwin A and Okon K: SOX-2, but not Oct4, is
highly expressed in early-stage endometrial adenocarcinoma and is
related to tumour grading. Int J Clin Exp Pathol. 8:8189–8198.
2015.PubMed/NCBI
|
|
13
|
Ishida H, Kasajima A, Kamei T, Miura T,
Oka N, Yazdani S, Ozawa Y, Fujishima F, Sakurada A, Nakamura Y, et
al: SOX2 and Rb1 in esophageal small-cell carcinoma: Their possible
involvement in pathogenesis. Mod Pathol. 30:660–671.
2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ebisu Y, Ishida M, Okano K, Sandoh K,
Mizokami T, Kita M, Okada H and Tsuta K: Small-cell neuroendocrine
carcinoma in directly sampled endometrial cytology: A monocentric
retrospective study of six cases. Diagn Cytopathol. 47:1297–1301.
2019.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Masai K, Tsuta K, Kawago M, Tatsumori T,
Kinno T, Taniyama T, Yoshida A, Asamura H and Tsuda H: Expression
of squamous cell carcinoma markers and adenocarcinoma markers in
primary pulmonary neuroendocrine carcinomas. Appl Immunohistochem
Mol Morphol. 21:292–297. 2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yemelyanova A, Ji H, Shih IeM, Wang TL, Wu
LS and Ronnett BM: Utility of p16 expression for distinction of
uterine serous carcinomas from endometrial endometrioid and
endocervical adenocarcinomas: Immunohistochemical analysis of 201
cases. Am J Surg Pathol. 33:1504–1514. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
McCluggage WG, Kennedy K and Busam KJ: An
immunohistochemical study of cervical neuroendocrine carcinomas:
Neoplasms that are commonly TTF1 positive and which may express
CK20 and P63. Am J Surg Pathol. 34:525–532. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ordóñez NG: Value of PAX 8 immunostaining
in tumor diagnosis: A review and update. Adv Anat Pathol.
19:140–151. 2012.PubMed/NCBI View Article : Google Scholar
|
